FTC remains aggressive in halting sales of unproven COVID-19 treatments

562
SHARE

The FTC’s warning letters targeted companies selling treatments including intravenous (IV) Vitamin C and D infusions, supposed stem cell therapy, vitamin injections, essential oils, CBD products, infrared heat, oral peroxide gel, and oxygen therapy.

Enter Email to View Articles

Loading...

Currently, there is no scientific evidence that any of the products, therapies, or services being marketed can treat or prevent COVID-19.

In the warning letters, the FTC told the companies or marketers that they are making unsubstantiated claims about their products or therapies. The Commission noted that the marketers do not have scientific evidence to support their claims. Therefore, they are violating the FTC Act.

The FTC advised the marketers to immediately stop making false claims about their products or therapies. The Commission also required them to submit in writing the specific actions they have taken to address its concerns.

Additionally, the FTC told recipients of warning letters that it will seek a federal court injunction and an order requiring refunds to consumers if they don’t stop their false claims.